Reportlinker Adds Global Regenerative Medicine Industry
NEW YORK, Nov. 18, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Regenerative Medicine Industry
http://www.reportlinker.com/p090567/Global-Regenerative-Medicine-Industry.html
This report analyzes the worldwide markets for Regenerative Medicine in US$ Million.The report provides separate comprehensive analytics for the US, Japan, and Europe. Annual estimates and forecasts are provided for the period 2009 through 2015. A six-year historic analysis is also provided for these markets. The report profiles 106 companies including many key and niche players such as BioVest International, Inc., Curis, Inc., Cytori Therapeutics, Inc., DeveloGen AG, Forticell Bioscience, Inc., Geron Corporation, Integra Orthobiologics, LifeCell Corporation, Osiris Therapeutics, Inc., Tengion, Tepha Inc., and TiGenix N.V. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
REGENERATIVE MEDICINE MCP-1241
A GLOBAL STRATEGIC BUSINESS REPORT
CONTENTS
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Data Interpretation & Reporting Level 2
Quantitative Techniques & Analytics 3
Product Definitions and Scope of Study 3
2. INDUSTRY OVERVIEW 4
Market Potential 4
Regenerative Medicine in Bone and Joint Applications 4
US Corners a Lion's Share 4
Regenerative Medicine - the Past, the Present, & the Future 4
Another Revolution in the Making? 5
Conventional Chemical Medicine Vs Regenerative Medicine 6
The Need for Regenerative Medicine 6
Regenerative Medicine Throws in Several New Therapies 7
What's in Store? 7
Regenerative Medicine to Arrest Ageing 7
Thriving on an Aging World Population 7
Faster Healing Process 8
Regenerative Medicine to Overcome Donor Organs Shortage 8
Possible Scenarios 8
Stem Cell Research - Not Just Another Medical Advancement 9
Key Issues At Play 9
Growth Drivers 10
Trends & Issues 10
Biomaterials Sought After in Regenerative Medicine 10
Upbeat Market for Cell-based Tissue Engineering 11
Progenitor Cell Therapy to Witness No Holds Barred Growth 11
Players Embrace Automation in Production Facilities 12
Contract Manufacturing, a Growing Sector 12
Investors Wary of Funding Regenerative Medicine 12
Regenerative Medicine Field Lags Behind due to Segregated Focus 13
Challenges to Be Encountered by Tissue Engineering Companies 13
Activity in the Field of Regenerative Medicine 14
3. PRODUCT OVERVIEW 15
Regenerative Medicine Advances in Four Phases 15
Human Substances 15
Tissue Engineering 15
Therapeutic Cloning 15
Nanotechnology-Driven Biomaterials 15
Types of Regenerative Medicine 16
Type I - Regenerative Medicine 16
Human Proteins and Genes are Drugs in Regenerative Medicine 16
Type-2 Regenerative Medicine 17
Therapies Based on Human Cells and Tissues 17
Type-3 Regenerative Medicine 18
Based on Embryonic Stem Cells 18
The Opponents of the ESC Theory 19
Embryonic Stem Cells - Shortcomings 19
Type-4 Regenerative Medicine 20
Based on Novel Materials / Material Science Advancements 20
Overview of Major Regenerative Medicine Techniques 21
Natural Regenerative Proteins 21
Tissue Engineering Capable of Culturing Replacement Organs 22
All About Stem Cells 22
Adult Stem Cells 23
Adult Stem Cell Research Eludes Ethical Dispute 23
hESC - Highly Capable of Differentiating and Multiplying 23
Stem Cell Research in Development of Regenerative Medicine 23
Neural Stem Cell to Restore Memory Functioning 24
Pancreatic Islet Cells to Control Blood Sugar in Diabetics 24
Therapeutic Cloning to Cure Parkinson's 24
4. REGULATORY ENVIRONMENT 25
Regulatory Norms Governing ES Cell Research 25
Milestones in the Human Embryonic Stem Cell Research: 2001 25
Legality of ES Cell Use in Major Developed Nations 25
5. TECHNOLOGICAL INNOVATIONS / BREAKTHROUGHS 26
Kensey Nash's Medeor ECM Receives Approval from US FDA 26
Celling Technologies Unveils Res-Q Device 26
Kinetic Wins FDA Approval for LifeCell Tissue Matrix 26
6. TECHNOLOGICAL INNOVATIONS IN RECENT PAST - A PERSPECTIVE BUILDER 28
Celprogen Launches 11 Cancer Stem Cells 28
Biovest International Launches AutovaxID™ 28
Stelic Institute Announces New Treatment Method for Acute
Liver Failure 28
TissueGene Initiates Phase 1 Clinical Trials for TG-C 29
ISTO Announces FDA's IND Approval for Neocartilage Graft 29
Cook Biotech Introduces Surgisis® AFP™ Anal Fistula Plug 29
Korean Scientists Make a Major Breakthrough in Stem Cell Lines 30
Japanese Researchers Regenerate Jaw Bone 30
Geron Researchers Differentiate Hepatocytes from hESCs 30
Geron Demonstrates Potential of hESCs in Treatment of
Parkinson's disease 31
Geron Researches Cardiomyocytes for Heart Disease 31
Endovasc Announces New Findings at Texas Heart Institute Research 31
Geron and Celera Genomics Complete Characterization of Active
Genes in hESCs 32
Rockefeller University Develops Solution for Maintaining
Plupotency in hESCs 32
7. RECENT INDUSTRY ACTIVITY 33
Power3 Medical Inks Definitive Agreement to Acquire StemTroniX 33
Healthpoint Acquires CYZACTTM and ICX-SKN Technologies from
Intercytex 33
Stem Cell Therapy International Merges with Histostem 33
TiGenix Acquires Orthomimetics 33
Integra Inks Licensing Deal with Organogenesis 34
DePuy Spine Collaborates with ATRM 34
Epistem Enters into Partnership with Novartis 34
Athersys Inks Agreement with Pfizer 34
Beike Biotechnology Signs Investment Agreement with Biomaster 34
Fujifilm Establishes New Drug Discovery Labs 35
KCI Acquires LifeCell 35
Organogenesis Takes Over NanoMatrix 35
Cytori and Green Hospital Supply Ink Strategic Equity Deal 35
Sigma-Aldrich Signs Agreement with AlphaGenix 36
RNL Bio Establishes Research Unit at Newcastle University 36
Pfizer Establishes New Regenerative Medicine Research Unit 36
Tengion Begins Third Phase II Clinical Trial of Neo-Bladder
Augment™ 36
8. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER 37
Integra Life Sciences Acquires IsoTis, Inc. 37
Geron Increases Stake in TA Therapeutics 37
Organogenesis Signs MoU with NTEC 37
BioTime Establishes New Stem Cell Division 38
NovaThera and Gamida Join Hands for Developing Cell
Therapeutics for Lung Regeneration 38
Tigenix Teams Up With Fidea to Develop Biological Joint Implants 38
Scotland Plans to Build Center for Regenerative Medicine in
Edinburgh 39
9. FOCUS ON SELECT GLOBAL PLAYERS 40
BioVest International, Inc. (US) 40
Curis, Inc. (US) 40
Cytori Therapeutics, Inc. (US) 41
DeveloGen AG (Germany) 41
Forticell Bioscience, Inc. (US) 42
Geron Corporation (US) 42
Integra Orthobiologics (US) 43
LifeCell Corporation (US) 44
Osiris Therapeutics, Inc. (US) 44
Tengion (US) 45
Tepha Inc. (US) 45
TiGenix N.V. (Belgium) 45
10. GLOBAL MARKET PERSPECTIVE 47
Table 1: World Recent Past, Current & Future Market Analysis
for Regenerative Medicine Products for Bone and Joint
Applications by Geographic Region - US, Japan and Europe
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2009 through 2015 (includes corresponding
Graph/Chart) 47
Table 2: World Historic Review for Regenerative Medicine
Products for Bone and Joint Applications by Geographic Region -
US, Japan, and Europe Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2003 through
2008 (includes corresponding Graph/Chart) 48
Table 3: World 11-Year Perspective for Regenerative Medicine
Products for Bone and Joint Applications by Geographic Region -
Percentage Breakdown of Dollar Sales for US, Japan and
Europe for Years 2005, 2010 & 2015 (includes corresponding
Graph/Chart) 49
11. THE UNITED STATES 50
A.Market Analysis 50
Market Potential 50
Regenerative Medicine in Bone and Joint Applications 50
Table 4: US Market for Regenerative Medicine Products for
Bone and Joint Applications (2007, 2010 & 2013):
Percentage Breakdown of Value Sales for Bone Replacement
Grafting, Bone Growth Stimulators, and Tissue Engineering
Cartilage (includes corresponding Graph/Chart) 51
Regenerative Therapy - Best Fit for Joint Problems 51
Millions of American Patients Put their Hope in Stem Cell
Research 52
Table 5: Prevalence of Various Diseases in the US (includes
corresponding Graph/Chart) 52
US Witnesses Mixed Response for Government Support for hESC
Research 52
CBI's Human Tissue Products for Treating Liver Failure and
Diabetes 53
Market for Liver and Pancreas Transplantation 53
Implantable Regenerative Products Take Over Sports Medicine 54
Key Players 54
Other Dominating Regional Players 54
B.Market Analytics 57
Table 6: US Recent Past, Current & Future Analysis for
Regenerative Medicine Products for Bone and Joint
Applications - Annual Sales Figures in US$ Million for Years
2009 through 2015 (includes corresponding Graph/Chart) 57
Table 7: US Historic Review for Regenerative Medicine
Products for Bone and Joint Applications Market with Annual
Sales Figures in US$ Million for Years 2003 through 2008
(includes corresponding Graph/Chart) 57
12. JAPAN 58
A.Market Analysis 58
Market Potential 58
Research Activity in Regenerative Medicine Field 58
More Companies Eye the Regenerative Medicine Potential 58
Competition Heats up Behind Closed Doors 59
Japanese Firms Need to Catch Up with US and European
Competitors 59
Science Ministry Rolls Out Regenerative Medicine Project 59
Regenerative Medicine Exempted from Ban on Human Cloning 60
B.Market Analytics 61
Table 8: Japanese Recent Past, Current & Future Analysis for
Regenerative Medicine Products for Bone and Joint
Applications with Annual Sales Figures in US$ Million for
Years 2009 through 2015 (includes corresponding Graph/Chart) 61
Table 9: Japanese Historic Review for Regenerative Medicine
Products for Bone and Joint Applications with Annual Sales
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 61
13. EUROPE 62
A.Market Analysis 62
Oral Tissue Regeneration 62
Table 10: European Oral Tissue Regeneration Market (2009):
Percentage Breakdown of Value Sales for Bone Graft
Material, Membranes, and Tissue Regeneration (includes
corresponding Graph/Chart) 62
Regional Overview 62
Germany 62
Key Players 62
United Kingdom 63
Belgium 63
Select Player 63
B.Market Analytics 64
Table 11: European Recent Past, Current & Future Analysis
for Regenerative Medicine Products for Bone and Joint
Applications with Annual Sales Figures in US$ Million for
Years 2009 through 2015 (includes corresponding Graph/Chart) 64
Table 12: European Historic Review for Regenerative Medicine
Products for Bone and Joint Applications Market with Annual
Sales Figures in US$ Million for Years 2003 through 2008
(includes corresponding Graph/Chart) 64
14. REVIEW OF REGENERATIVE MEDICINE IN OTHER GEOGRAPHIC MARKETS 65
14a. CANADA 65
University of Toronto - Spearheading Regenerative Medicine
Research 65
14b. ASIA-PACIFIC 65
China 65
Substantial Government Support 65
India 66
CSIR- Leading the way in Regenerative Medicine Research 66
High Growth Opportunities 66
Australia 66
Key Player 66
Stem Cell Sciences 66
South Korea 67
Malaysia 67
Singapore 67
14c. REST OF WORLD 68
Argentina 68
Israel 68
Select Major Players 68
Colbar R&D Ltd. 68
ProChon Biotech Ltd. 68
South Africa 69
COMPETITION
Total Companies Profiled: 106 (including Divisions/Subsidiaries - 111)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 60
Canada 2
Japan 12
Europe 20
Germany 6
The United Kingdom 6
Italy 1
Rest of Europe 7
Asia-Pacific (Excluding Japan) 9
Latin America 1
Africa 4
Middle-East 3
------------------------------------------
To order this report:
Blood Supply, Tissue Banking and Transplantation Industry: Global Regenerative Medicine Industry
Blood Supply, Tissue Banking and Transplantation Business News
Check our Company Profile, SWOT and Revenue Analysis!
Contact Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article